Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies
about
Antibody phage display libraries: contributions to oncology.Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.TRAIL on trial: preclinical advances in cancer therapyEffect of naive and radiolabeled rhTRAIL on the cervical cancer xenografts in mice.Stem cells in cancer therapy: opportunities and challenges.
P2860
Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Development of a radioiodinate ...... y for clinical imaging studies
@en
Development of a radioiodinate ...... for clinical imaging studies.
@nl
type
label
Development of a radioiodinate ...... y for clinical imaging studies
@en
Development of a radioiodinate ...... for clinical imaging studies.
@nl
prefLabel
Development of a radioiodinate ...... y for clinical imaging studies
@en
Development of a radioiodinate ...... for clinical imaging studies.
@nl
P2093
P2860
P1476
Development of a radioiodinate ...... y for clinical imaging studies
@en
P2093
A G J van der Zee
E C F Dijkers
E G E de Vries
E W Duiker
H Lambers Heerspink
J G W Kosterink
M N Lub-de Hooge
P2860
P304
P356
10.1111/J.1476-5381.2011.01718.X
P407
P577
2012-04-01T00:00:00Z